Juan Graham - Dec 9, 2022 Form 4/A - Amendment Insider Report for FIBROGEN INC (FGEN)

Role
Chief Financial Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Dec 9, 2022
Transactions value $
-$32,031
Form type
4/A - Amendment
Date filed
12/15/2022, 04:23 PM
Date Of Original Report
Dec 14, 2022
Previous filing
Dec 15, 2022
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$11.6K -781 -1.56% $14.89* 49.4K Dec 9, 2022 Direct F1, F2
transaction FGEN Common Stock Sale -$20.4K -1.41K -2.85% $14.50* 48K Dec 12, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
F2 These shares were sold in multiple transactions on the reported date with prices ranging from $14.667 to $14.8936 resulting in a weighted average price of $14.89. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.
F3 Shares sold pursuant to a 10b5-1 plan.

Remarks:

This amendment is being file to include the sales price range and to update Column 5 for number of beneficially held shares.